122 related articles for article (PubMed ID: 1961006)
1. Mechanisms of resistance to chlorambucil in chronic lymphocytic leukemia.
Begleiter A; Goldenberg GJ; Anhalt CD; Lee K; Mowat MR; Israels LG; Johnston JB
Leuk Res; 1991; 15(11):1019-27. PubMed ID: 1961006
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase activity, sulfhydryl group and glutathione levels, and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia.
Johnston JB; Israels LG; Goldenberg GJ; Anhalt CD; Verburg L; Mowat MR; Begleiter A
J Natl Cancer Inst; 1990 May; 82(9):776-9. PubMed ID: 2325147
[TBL] [Abstract][Full Text] [Related]
3. Chlorambucil in chronic lymphocytic leukemia: mechanism of action.
Begleiter A; Mowat M; Israels LG; Johnston JB
Leuk Lymphoma; 1996 Oct; 23(3-4):187-201. PubMed ID: 9031099
[TBL] [Abstract][Full Text] [Related]
4. Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient.
Petrini M; Conte A; Caracciolo F; Sabbatini A; Grassi B; Ronca G
Br J Haematol; 1993 Oct; 85(2):409-10. PubMed ID: 8280615
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance mechanisms in chronic lymphocytic leukemia.
Ribrag V; Massade L; Faussat AM; Dreyfus F; Bayle C; Gouyette A; Marie JP
Leukemia; 1996 Dec; 10(12):1944-9. PubMed ID: 8946935
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs.
Silber R; Degar B; Costin D; Newcomb EW; Mani M; Rosenberg CR; Morse L; Drygas JC; Canellakis ZN; Potmesil M
Blood; 1994 Nov; 84(10):3440-6. PubMed ID: 7949099
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L
Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813
[TBL] [Abstract][Full Text] [Related]
8. Studies on drug resistance in chronic lymphocytic leukemia.
Silber R; Potmesil M; Bank BB
Adv Enzyme Regul; 1989; 29():267-76. PubMed ID: 2561248
[TBL] [Abstract][Full Text] [Related]
9. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients.
Schisselbauer JC; Silber R; Papadopoulos E; Abrams K; LaCreta FP; Tew KD
Cancer Res; 1990 Jun; 50(12):3562-8. PubMed ID: 2340505
[TBL] [Abstract][Full Text] [Related]
10. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
[TBL] [Abstract][Full Text] [Related]
11. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
Christodoulopoulos G; Malapetsa A; Schipper H; Golub E; Radding C; Panasci LC
Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
[TBL] [Abstract][Full Text] [Related]
12. In vitro cytotoxicity of 2-chlorodeoxyadenosine and chlorambucil in chronic lymphocytic leukemia.
Begleiter A; Wang H; Verburg L; Lee K; Israels LG; Mowat MR; Johnston JB
Leukemia; 1996 Dec; 10(12):1959-65. PubMed ID: 8946937
[TBL] [Abstract][Full Text] [Related]
13. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
Yang WZ; Begleiter A; Johnston JB; Israels LG; Mowat MR
Mol Pharmacol; 1992 Apr; 41(4):625-30. PubMed ID: 1569917
[TBL] [Abstract][Full Text] [Related]
14. DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards.
Muller C; Christodoulopoulos G; Salles B; Panasci L
Blood; 1998 Oct; 92(7):2213-9. PubMed ID: 9746757
[TBL] [Abstract][Full Text] [Related]
15. Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.
Panasci L; Paiement JP; Christodoulopoulos G; Belenkov A; Malapetsa A; Aloyz R
Clin Cancer Res; 2001 Mar; 7(3):454-61. PubMed ID: 11297233
[TBL] [Abstract][Full Text] [Related]
16. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
[TBL] [Abstract][Full Text] [Related]
17. Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy.
Begleiter A; Lee K; Israels LG; Mowat MR; Johnston JB
Leukemia; 1994 Apr; 8 Suppl 1():S103-6. PubMed ID: 8152273
[TBL] [Abstract][Full Text] [Related]
18. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
Morabito F; Stelitano C; Callea I; Filangeri M; Oliva B; Sculli G; Callea V; Nobile F; Brugiatelli M
Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527
[TBL] [Abstract][Full Text] [Related]
19. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Chlorambucil and Valproic Acid on Cell Viability, Apoptosis and Expression of
Lipska K; Filip A; Gumieniczek A
Cells; 2021 May; 10(5):. PubMed ID: 34063233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]